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Second University of Naples, Naples, Italy
Successful tissue engineering requires functional vascularization of the three-dimensional
constructs with the aim to serve as implants for tissue replacement and regeneration.
The survival of the implant is only possible if the supply of oxygen and nutrients by
developing capillaries from the host is established. The chorioallantoic membrane (CAM)
assay is a valuable tool to study the ingrowth and distribution of vessels into scaffolds
composed by appropriate biomaterials and stem cell populations that are used in
cell-based regenerative approaches. The developing vasculature of chicken embryos
within cell-seeded scaffolds can be visualized with microcomputed tomography after
intravenous injection of MicroFil®, which is a radiopaque contrast agent. Here, we provide
a step-by-step protocol for the seeding of stem cells into silk fibroin scaffolds, the CAM
culture conditions, the procedure of MicroFil® perfusion, and finally the microcomputed
tomography scanning. Three-dimensional imaging of the vascularized tissue engineered
constructs provides an important analytical tool for studying the potential of cell seeded
scaffolds to attract vessels and form vascular networks, as well as for analyzing the
number, density, length, branching, and diameter of vessels. This in ovo method can
greatly help to screen implants that will be used for tissue regeneration purposes before
their in vivo testing, thereby reducing the amount of animals needed for pre-clinical
studies.
Keywords: chorioallantoic membrane (CAM), vascularization, stem cells, biomaterials, 3D imaging, MicroFil®,
microcomputed tomography, regenerative medicine
INTRODUCTION
The formation of new networks of blood vessels (i.e., angiogenesis) is essential in embryonic
development, tissue homeostasis, pathology, and regeneration. Hematopoietic cells circulating
within the vasculature supply the surrounding tissues with oxygen and nutrients, transport
hormones, remove waste products, and CO2, and protect the body from infections (Carmeliet
and Jain, 2011). Successful engineering of tissue substitutes and transplantable organs depends
on their rapid and adequate angiogenesis, since the appropriate supply of oxygen and nutrients
is crucial for their long-term survival (Mitsiadis and Harada, 2015; Mitsiadis et al., 2015). A dense
network of capillaries is formed in most tissues of the body that regulates the diffusion limit of
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oxygen (Carmeliet and Jain, 2000; Novosel et al., 2011).
Spontaneous vascular ingrowth from the host tissue to the
transplanted devices (e.g., empty biodegradable implants) is
very slow and limited to several tenths of micrometers per
day (Rouwkema et al., 2008). Therefore, the improvement and
acceleration of implant vascularization remains a key challenge
in regenerative medicine.
Classical in vivo angiogenesis assays rely on small (e.g.,
mice, rats) and large (e.g., sheep, goats) animal models,
where engineered constructs are most commonly implanted
subcutaneously at their dorsal part (Staton et al., 2009;
Jungraithmayr et al., 2013; Wang et al., 2015). However,
these surgical procedures are time-consuming and often
associated with high costs and repetitive animal sacrifice. The
chorioallantoic membrane (CAM) is highly vascularized and
serves as a transient gas exchange surface during the incubation
period, similar to the lung (Romanoff, 1960). Originally, the
CAM assay was used in order to study the developmental
potential of embryonic tissue grafts (Rücker et al., 2006). As
chicken embryos become immunocompetent only by day 18
of their development (Jankovic´ et al., 1975), various biological
processes where vascularization plays a role can be studied
without inducing an immune response, including insufficient
vascularization (e.g., ischemic disorders) or excessive vessel
formation (e.g., cancer), with the goal to either enhance or
decrease vessel growth, respectively (Ribatti, 2014).
To visualize the three-dimensional (3D) development of the
vasculature within implants cultured on the CAM, perfusion of
the chicken embryos was performed with the radiopaque contrast
agent MicroFil R© followed by microcomputed tomography
(microCT) of the implants. We demonstrate that this technique,
which is commonly used in in vivo experiments performed
in rodents (Bolland et al., 2008; Schmidt et al., 2009;
Stoppato et al., 2013), can also successfully be applied in the
CAM assay.
MATERIALS AND METHODS
Seeding of Human Dental Pulp Stem Cells
a. Defrost cryopreserved human dental pulp stem cells and
culture in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12 (DMEM/F12) + 10% fetal bovine serum +
1% penicillin/streptamycin + 0.5 µg/mL fungizone in a
humidified incubator at 37◦C and 5% CO2. Change the
medium every 3–4 days.
b. At 80–90% confluency, trypsinize the cells, use a 70
µm strainer to obtain a single-cell suspension, centrifuge
(1500 rpm, 5min, RT), and resuspend the cell pellet at a
concentration of 1× 106 cells/50 µL.
c. Place the sterile cylindrical scaffold (silk fibroin, 5mm
diameter, 3mm height) on a sterile filter paper to absorb
any residual liquid and move the scaffold into the well of a
96-well-plate.
d. Seed the scaffold by pipetting 50 µL of the cell suspension on
top of the scaffold, turn the scaffold, take up the cell suspension
from the bottom of the well, and release it again on top of the
scaffold.
e. For cell attachment, place the cell-seeded scaffolds in a
humidified incubator for 1 h at 37◦C and 5% CO2. Wash the
scaffold before placing it in a clean well of a 24-well-plate and
adding 1 mL of medium. Culture for desired period of time
and change medium every 3–4 days.
The procedure for anonymized cell collection was approved by
the Kantonale Ethikkommission of Zurich and performed with
written patients’ consent.
Preparation of the Chicken Eggs for the
CAM Assay and Placing of the Cell-Seeded
Samples
a. Pre-incubate fertilized Lohman white LSL (Lohman Selected
Leghorn) chicken eggs in an egg incubator for 3 days at 38◦C
at a rotation speed of 360◦/4 h.
b. On embryonic day 3 (ED 3), stop the rotation in the morning
and let the eggs rest in this position for 3 h to ensure that the
embryo is on the top.
c. Mark the top of the egg with a pencil and carefully wipe the
egg-shell with 70% ethanol without turning it.
d. Inside a clean bench, place the egg in a 60 mm Petri dish on
top of a piece of tape to stabilize the egg.
e. Make a small hole in the shell with the tip of sterile pointy
scissors and remove 4 mL of albumen using a syringe and a
needle to lower the developing embryo.
f. Put ScotchTM tape on the area where you want to make the
window.
g. Make another small hole, insert the scissors carefully and start
cutting an oval hole while turning the egg with the other hand.
h. Remove the shell and cover the opening with a second 60 mm
Petri dish, which needs to be fixed to the bottom lid with tape,
and incubate in a humidified incubator at 37◦C and 0% CO2.
i. On ED 7, the cell-seeded scaffolds can be placed on the
vascularized CAM. Remove the Petri dish lid, place a silicone
ring (taken from sterile cryovials) on the CAM to ensure a flat
surface, and position the sample in the middle of this ring.
j. Incubate for 7 days until ED 14 in a humidified incubator at
37◦C and 0% CO2.
Microfil® Perfusion and Microct Imaging
a. On ED 14, the chicken embryos are perfused with a mix of the
MicroFil R© components. Dilute the silicone rubber injection
compound (yellow) 10-fold in MV-Diluent and add 10% (by
weight) MV-Curing Agent right before use. Working time is
at least 20min and starts with the addition of curing agent.
b. Fill the MicroFil R© mix into a 5mL syringe and attach a three-
way valve (Discofix R© C) with a 10 cm tube for more flexibility
between the 30G ½” needle and the syringe.
c. Using a stereoscope, fix a branch of the vitelline vasculature
matching the diameter of the needle with blunt end tweezers
and carefully insert the needle into the vessel. Apply a small
drop of superglue where the needle enters the vasculature
(Figure 1).
d. Inject the MicroFil R© mix carefully into the vasculature until
the pressure increases.
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FIGURE 1 | Setup for the perfusion of the chorioallantoic membrane
vasculature. The scaffold is placed in the middle of a silicone ring and
cultured for 7 days in ovo. For proper perfusion a 30G ½” needle is fixed with a
drop of superglue before MicroFil® (yellow) injection.
e. If filling of the vasculature is not sufficient, inject MicroFil R©
a second time into a non-perfused vessel. Remove the tube
from the needle, which remains in the CAM, and attach a fresh
needle to the tube. Repeat steps c and d.
f. Place the perfused chicken embryo overnight at 4◦C for
complete curing of the MicroFil R©.
g. On the next day, remove the perfused scaffold samples
from the CAM using scissors, wash in PBS, fix in 4%
paraformaldehyde, wash in PBS, and place in 70% ethanol
until microCT imaging.
h. Perform microCT scanning at an isotropic resolution of 20
µm, an energy level of 70 kVp, an intensity of 114 µA, and
300 ms integration time.
According to Swiss animal care guidelines experiments
performed in chicken embryos until ED 14 do not need ethical
approval (TSchV, Art. 112).
RESULTS
We have used the CAM assay to study the vascularization
of a 3D biomaterial when placed in a highly vascularized
environment. The perfusion of the vascular system was
performed without pre-perfusion with phosphate buffered saline,
as the blood was forced out by the injected MicroFil R©. The
initial perfusion efficiency with MicroFil R© diluted according to
the manufacturer’s recommendation was improved by using a
higher dilution of the silicone rubber injection compound, which
required an increased amount of the MV-Curing Agent of 10%
instead of 5% (by weight). If the perfusion was not complete
after one injection, a second injection site was chosen to fill non-
perfused areas (Figures 2A,B). Immunohistological stainings can
still be performed on sections of paraffin-embedded samples after
perfusion and microCT analysis (Figure 2C).
The microCT scan showed the MicroFil R© perfused 3D
vascular structure growing into the scaffold (red area in
FIGURE 2 | Macroscopical and microscopical view of perfused
samples. (A) Perfused (yellow) and non-perfused (red) vessels after one
injection showing incomplete perfusion. (B) Exemplary sample after two
injections of MicroFil®. (C) Histological section of a perfused sample showing
vessels (brown) containing MicroFil®.
Figure 2B) from the bottom and from the sides within 7 days of
in ovo culture.While themacroscopical image of the same sample
in ovo (Figure 3A) provides only the information about the
vascularization visible on the surface of the CAM, the microCT
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FIGURE 3 | Stem cell-seeded scaffolds perfused with MicroFil® after
their in ovo culture. (A) Macroscopic view of a scaffold (green dashed line)
immediately after perfusion with yellow MicroFil®. The silicone ring is seen in
white, vasculature in yellow. (B) Microcomputed tomography image of the
vascular cast within the scaffold (red color). Vasculature outside the scaffold
area is marked in brown. New capillaries are sprouting from one large vessel
that encircles the scaffold (white arrows).
image visualizes the whole vascular network. Interestingly, new
capillaries are sprouting from one large vessel that encircles the
scaffold, (Figure 3B, white arrows). The generated microCT data
can be further used for complete morphometric characterization
of the vascular network, including the number, length, branching,
and diameter of vessels.
DISCUSSION
The generation of vascularized tissues and organs remains one
of the key challenges in regenerative medicine (Novosel et al.,
2011; Mitsiadis et al., 2012; Dew et al., 2015). Visualization
of angiogenesis within implanted engineered devices aiming at
tissue replacement and/or regeneration is pivotal for predicting
and understanding the outcome of new regenerative approaches
before their application in clinics.
Several techniques have been extensively used to study
the vascular architecture of the whole body, as well as the
microvasculature of specific organs and tissues in both health
and disease. The development of new visualization methods
using microcomputed tomography (microCT) improved our
knowledge on specific tissue anatomy, physiology, and pathology
tremendously. Further, developments using perfusion of tissues
and organs before microCT scanning allowed additional analyses
at the histological level and generated a plethora of volumetric
and quantitative data (Garcia-Sanz et al., 1998). Therefore,
the combination of vascular perfusion with microCT imaging
and analysis has been applied in many fields, including
embryonic vascular development (Anderson-Berry et al., 2005),
cancer research (Xuan et al., 2007), cardiac disease models
(Sangaralingham et al., 2012), and tissue engineering (Bolland
et al., 2008; Stoppato et al., 2013). For example, the combination
of MicroFil R© perfusion with microCT imaging has been used
to study angiogenesis in tissue engineered constructs implanted
subcutaneously into immunosuppressed mice. Both natural
allografts and osteosynthetic [poly (D,L)-lactic acid; PDLLA]
grafts seeded with human bone marrow stromal cells (BMSCs)
have been used for this study. The presence of BMSCs was
able to increase the number of vessels within the implants
(Bolland et al., 2008). Similarly, MicroFil R© perfusion and
microCT scanning have been performed in VEGF-treated
porous polyurethane scaffolds implanted subcutaneously into
rats (Schmidt et al., 2009). A more recent study using MicroFil R©
perfusion and microCT scanning has demonstrated that silk
fibroin fibers combined with a PDLLA salt-leached sponge
promoted vascularization when implanted subcutaneously into
rats (Stoppato et al., 2013).
However, all these previous studies are based on rodents
and therefore necessitate extensive animal care-taking, ethical
approvals, as well as surgical skills and equipment. Moreover,
a minimum of 10 days incubation time is needed in order to
analyze implant vasculature. In contrast, the CAM assay is a
simple, cost-effective, and highly reproducible method, which
does not require ethical approval when performing experiments
in chicken embryos until embryonic day 14 (Swiss animal care
guidelines, TSchV, Art. 112). Even though the incubation time
on the CAM is limited to a period of 7 days, it constitutes
an excellent screening method to study the early phase of
angiogenesis within implanted scaffolds. Following the “3Rs”
principles of replacement, refinement, and reduction of animal
use in research, the CAM assay combined with MicroFil R©
perfusion and microCT analysis as described in this protocol
provides a valuable intermediate platform for initial assessments
prior to pre-clinical studies in mammals.
This technique could be applied for the direct comparison of
scaffolds (ceramics, synthetic polymers, and natural polymers)
seeded with stem cell populations of different origins [e.g.,
adipose-derived stem cells (ASCs), bone marrow stem cells
(BMSCs), DPSCs, periodontal ligament stem cells]. For example,
it has been shown that BMSCs possess angiogenic potential
(Oswald et al., 2004), but little is known about their capability
to attract vessels in engineered structures. In contrast, ASCs
have been demonstrated to promote the neovascularization when
seeded in different scaffolds (De Francesco et al., 2009; Chan
et al., 2016; Guo et al., 2016). In conclusion, the present method
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can constitute a valuable tool for studying in detail cell-mediated
vascularization efficiency.
AUTHOR CONTRIBUTIONS
AW: experimental design, performance of experiments, writing
of the manuscript, editing, discussing. DL: experimental design,
writing of the manuscript, editing, discussing. TM: experimental
design, writing of the manuscript, editing, discussing.
FUNDING
This work was supported by the Swiss National
Foundation (SNSF) grant 31003A_135633 (TM, AW),
by institutional funds from University of Zurich (TM)
and by funds from the Second University of Naples
(SUN;DL).
ACKNOWLEDGMENTS
The authors thank Dr. Bernd Stadlinger and Dr. Philipp
Sahrmann of the Clinic for Dental Medicine for providing
teeth for dental pulp stem cell extraction. Furthermore, Trudel
Silk Inc. (Zurich, Switzerland) is highly acknowledged for
providing silk fibroin and the Institute of Biomechanics,
ETH for manufacturing the scaffolds. Further, we thank
Dr. Johanna Buschmann for technical advice and valuable
discussions.
REFERENCES
Anderson-Berry, A., O’Brien, E. A., Bleyl, S. B., Lawson, A., Gundersen, N.,
Ryssman, D., et al. (2005). Vasculogenesis drives pulmonary vascular growth in
the developing chick embryo.Dev. Dyn. 233, 145–153. doi: 10.1002/dvdy.20296
Bolland, B. J., Kanczler, J. M., Dunlop, D. G., and Oreffo, R. O. (2008).
Development of in vivo µCT evaluation of neovascularisation in
tissue engineered bone Constructs. Biomaterials 43, 195–202. doi:
10.1016/j.bone.2008.02.013
Carmeliet, P., and Jain, R. K. (2000). Angiogenesis in cancer and other diseases.
Nature 407, 249–257. doi: 10.1038/35025220
Carmeliet, P., and Jain, R. K. (2011). Molecular mechanisms and clinical
applications of angiogenesis. Nature 473, 298–307. doi: 10.1038/nature10144
Chan, E. C., Kuo, S. M., Kong, A. M., Morrison, W. A., Dusting, G. J., Mitchell,
G. M., et al. (2016). Three dimensional collagen scaffold promotes intrinsic
vascularisation for tissue engineering applications. PLoS ONE 11:e0149799. doi:
10.1371/journal.pone.0149799
De Francesco, F., Tirino, V., Desiderio, V., Ferraro, G., D’Andrea, F., Giuliano,
M., et al. (2009). Human CD34+/CD90+ ASCs are capable of growing as
sphere clusters, producing high levels of vegf and forming capillaries. PLoSONE
4:e6537. doi: 10.1371/journal.pone.0006537
Dew, L., MacNeil, S., and Chong, C. K. (2015). Vascularization strategies for tissue
engineers. Regen. Med. 10, 211–224. doi: 10.2217/rme.14.83
Garcia-Sanz, A., Rodriguez-Barbero, A., Bentley, M. D., Ritman, E. L., and
Romero, J. C. (1998). Three-dimensional microcomputed tomography of renal
vasculature in rats. Hypertension 31, 440–444. doi: 10.1161/01.HYP.31.1.440
Guo, L. Z., Kim, T. H., Han, S., and Kim, S. W. (2016). Angio-vasculogenic
properties of endothelial-inducedmesenchymal stem cells derived from human
adipose tissue. Circ. J. 80, 998–1007. doi: 10.1253/circj.CJ-15-1169
Jankovic´, B. D., Isakovic´, K., Lukic´, M. L., Vujanovic´, N. L., Petrovic´, S., and
Markovic´, B. M. (1975). Immunological capacity of the chicken embryo. I.
Relationship between the maturation of lymphoid tissues and the occurrence
of cell-mediated immunity in the developing chicken embryo. Immunology 29,
497–508.
Jungraithmayr, W., Laube, I., Hild, N., Stark, W. J., Mihic-Probst, D., Weder,
W., et al. (2013). Bioactive nanocomposite for chest-wall replacement:
cellular response in a murine model. J. Biomater. Appl. 29, 36–45. doi:
10.1177/0885328213513621
Mitsiadis, T. A., and Harada, H. (2015). Regenerated teeth: the future of tooth
replacement. An update. Regen. Med. 10, 5–8. doi: 10.2217/rme.14.78
Mitsiadis, T. A., Orsini, G., and Jimenez-Rojo, L. (2015). Stem cell based
approaches in dentistry. Eur. Cell and Mat. 30, 248–257.
Mitsiadis, T. A., Woloszyk, A., and Jiménez-Rojo, L. (2012). Nanodentistry:
combining nanostructured materials and stem cells for dental tissue
regeneration. Nanomedicine (Lond). 7, 1743–1753. doi: 10.2217/nnm.12.146
Novosel, E. C., Kleinhans, C., and Kluger, P. J. (2011). Vascularization is the
key challenge in tissue engineering. Adv. Drug Deliv. Rev. 63, 300–311. doi:
10.1016/j.addr.2011.03.004
Oswald, J., Boxberger, S., Jørgensen, B., Feldmann, S., Ehninger, G., Bornhäuser,
M., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial
cells in vitro. Stem Cells 22, 377–384. doi: 10.1634/stemcells.22-3-377
Ribatti, D. (2014). The chick embryo chorioallantoic membrane as a model for
tumor biology. Exp. Cell Res. 328, 314–324. doi: 10.1016/j.yexcr.2014.06.010
Romanoff, A. L. (1960). The Avian Embryo: Structural and Funtional Development,
1st Edn. New York, NY: The Macmillan Co.
Rouwkema, J., Rivron, N. C., and van Blitterswijk, C. A. (2008).
Vascularization in tissue engineering. Trends Biotechnol. 26, 434–441.
doi: 10.1016/j.tibtech.2008.04.009
Rücker, M., Laschke, M. W., Junker, D., Carvalho, C., Schramm, A., Mülhaupt,
R., et al. (2006). Angiogenic and inflammatory response to biodegradable
scaffolds in dorsal skinfold chambers of mice. Biomaterials 27, 5027–5038. doi:
10.1016/j.biomaterials.2006.05.033
Sangaralingham, S. J., Ritman, E. L., McKie, P. M., Ichiki, T., Lerman, A.,
Scott, C. G., et al. (2012). Cardiac micro-computed tomography imaging of
the aging coronary vasculature. Circ. Cardiovasc. Imaging 5, 518–524. doi:
10.1523/JNEUROSCI.3593-07.2007.Omega-3
Schmidt, C., Bezuidenhout, D., Beck, M., Van der Merwe, E., Zilla, P., and
Davies, N. (2009). Rapid three-dimensional quantification of VEGF-induced
scaffold neovascularisation by microcomputed tomography. Biomaterials 30,
5959–5968. doi: 10.1016/j.biomaterials.2009.07.044
Staton, C. A., Reed, M. W., and Brown, N. J. (2009). A critical analysis of current
in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 90, 195–221. doi:
10.1111/j.1365-2613.2008.00633.x
Stoppato, M., Stevens, H. Y., Carletti, E., Migliaresi, C., Motta, A., and Guldberg,
R. E. (2013). Effects of Silk Fibroin Fiber Incorporation on Mechanical
Properties, Endothelial Cell Colonization and Vascularization of PDLLA
Scaffolds. Biomaterials 34, 4573–4581. doi: 10.1016/j.biomaterials.2013.02.009
Wang, K., Yu, L. Y., Jiang, L. Y., Wang, H. B., Wang, C. Y., and Luo, Y. (2015).
The paracrine effects of adipose-derived stem cells on neovascularization and
biocompatibility of amacroencapsulation device.Acta Biomater. 15, 65–76. doi:
10.1016/j.actbio.2014.12.025
Xuan, J. W., Bygrave, M., Jiang, H., Valiyeva, F., Dunmore-Buyze, J., and
Holdsworth, D. W. (2007). Functional neoangiogenesis imaging of genetically
engineered mouse prostate cancer using three-dimensional power doppler
ultrasound. Cancer Res. 67, 2830–2839. doi: 10.1158/0008-5472.CAN-06-3944
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Woloszyk, Liccardo and Mitsiadis. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 5 April 2016 | Volume 7 | Article 146
